JHL Consultants

Medical Applications

Clinical Applications

BP Companion is intended to complement, not replace, standard clinical blood pressure assessment. It is particularly suited to the following scenarios:

•     Monitoring of antihypertensive therapy effectiveness across all four derived metrics simultaneously

•     Detection of white-coat and masked hypertension phenotypes through longitudinal home monitoring

•     Identification of arterial stiffening in patients with cardiovascular risk factors, using the FPP and PP trends

•     Assessment of resting cardiac workload in patients with known coronary artery disease, using RPP

•     Detection of high BP variability in patients whose mean pressures appear satisfactory

•     Generation of structured PDF reports for inclusion in consultation documentation or specialist referrals

     Limitations and Caveats

BP Companion is explicitly designed as an informational tool and does not provide diagnostic or therapeutic recommendations. The following limitations should be noted:

•     All measurements are brachial, using a standard upper-arm sphygmomanometer. Central aortic indices, which carry additional predictive value, are not directly measured.

•     FPP and PP norms are derived from population studies predominantly conducted in European and Asian cohorts; individual variation is substantial.

•     ARV is sensitive to measurement technique and timing; patient education regarding standardised measurement conditions is important.

•     RPP is a correlate, not a direct measure, of myocardial oxygen consumption; its accuracy depends on the accuracy of the underlying systolic and heart rate measurements.

•     Interpretation of trends requires clinical context and should be performed by a qualified healthcare professional.